Aditxt (ADTX) Shares Outstanding (Weighted Average) (2019 - 2026)
Aditxt (ADTX) recorded quarterly Shares Outstanding (Weighted Average) of $248568.0 in Q1 2026, up 565.42% quarter-over-quarter from $37355.0 in Q4 2025, and up 857031.03% on a YoY basis from N/an in Q1 2025.
Aditxt (ADTX) Shares Outstanding (Weighted Average) (2019 - 2026) Analysis & Trends
Aditxt's Shares Outstanding (Weighted Average) history runs 8 years deep, the most recent figure standing at $248568.0 for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 857031.03% year-over-year to $248568.0; the TTM figure through Mar 2026 stood at $248568.0 (up 857031.03% YoY), while the FY2025 annual figure was $37355.0, up 1867650.0% from the prior year.
- Shares Outstanding (Weighted Average) was $248568.0 for Q1 2026 at Aditxt, up from $37355.0 in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $6.4 million in Q3 2022 to a low of $2.0 in Q3 2024.
- Historically, Shares Outstanding (Weighted Average) has averaged $604113.6 across 5 years, with a median of $43816.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) slumped 99.95% in 2024, then surged 2190700.0% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $46369.0 in 2022, then tumbled by 97.39% to $1209.0 in 2023, then slumped by 99.83% to $2.0 in 2024, then surged by 1867650.0% to $37355.0 in 2025, then jumped by 565.42% to $248568.0 in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $248568.0 (Q1 2026), $37355.0 (Q4 2025), and $43816.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 185,491.37 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 400.00 Bn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 100.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 417.01 Bn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 118.76 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 68.88 Bn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 254.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 928.40 Mn |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | 248,568.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 248,568.00 |
| Dec 31, 2025 | 37,355.00 |
| Sep 30, 2025 | 43,816.00 |
| Jun 30, 2025 | 1.41 Mn |
| Mar 31, 2025 | 29.00 |
| Dec 31, 2024 | 2.00 |
| Sep 30, 2024 | 2.00 |
| Jun 30, 2024 | 7,210.00 |
| Mar 31, 2024 | 161.00 |
| Dec 31, 2023 | 1,209.00 |
| Sep 30, 2023 | 3,940.00 |
| Jun 30, 2023 | 134,371.00 |
| Mar 31, 2023 | 114,072.00 |
| Dec 31, 2022 | 46,369.00 |
| Sep 30, 2022 | 6.42 Mn |
| Jun 30, 2022 | 911,213.00 |
| Mar 31, 2022 | 891,614.00 |
| Dec 31, 2021 | 381,811.00 |
| Sep 30, 2021 | 347,610.00 |
| Jun 30, 2021 | 875,000.00 |